A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs
Clinical trial NCT00649844 · COMPLETED
Trial details
- NCT number
- NCT00649844
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.